Currently, novel coronavirus disease 2019 (COVID-19) is a big threat to global health. The rapid spread of the virus has created pandemic, and countries all over the world are struggling with a surge in COVID-19 infected cases. There are no drugs or other therapeutics approved by the US Food and Drug Administration to prevent or treat COVID-19: information on the disease is very limited and scattered even if it exists. This motivates the use of data integration, combining data from diverse sources and eliciting useful information with a unified view of them. In this paper, we propose a Bayesian hierarchical model that integrates global data for real-time prediction of infection trajectory for multiple countries. Because the proposed model takes advantage of borrowing information across multiple countries, it outperforms an existing individual country-based model. As fully Bayesian way has been adopted, the model provides a powerful predictive tool endowed with uncertainty quantification. Additionally, a joint variable selection technique has been integrated into the proposed modeling scheme, which aimed to identify possible country-level risk factors for severe disease due to COVID-19.
Bayesian optimization (BO) is an indispensable tool to optimize objective functions that either do not have known functional forms or are expensive to evaluate. Currently, optimal experimental design is always conducted within the workflow of BO leading to more efficient exploration of the design space compared to traditional strategies. This can have a significant impact on modern scientific discovery, in particular autonomous materials discovery, which can be viewed as an optimization problem aimed at looking for the maximum (or minimum) point for the desired materials properties. The performance of BO-based experimental design depends not only on the adopted acquisition function but also on the surrogate models that help to approximate underlying objective functions. In this paper, we propose a fully autonomous experimental design framework that uses more adaptive and flexible Bayesian surrogate models in a BO procedure, namely Bayesian multivariate adaptive regression splines and Bayesian additive regression trees. They can overcome the weaknesses of widely used Gaussian process-based methods when faced with relatively high-dimensional design space or non-smooth patterns of objective functions. Both simulation studies and real-world materials science case studies demonstrate their enhanced search efficiency and robustness.
Currently, novel coronavirus disease 2019 (COVID-19) is a big threat to global health. The rapid spread of the virus has created pandemic, and countries all over the world are struggling with a surge in COVID-19 infected cases. There are no drugs or other therapeutics approved by the US Food and Drug Administration to prevent or treat COVID-19: information on the disease is very limited and scattered even if it exists. This motivates the use of data integration, combining data from diverse sources and eliciting useful information with a unified view of them. In this paper, we propose a Bayesian hierarchical model that integrates global data for real-time prediction of infection trajectory for multiple countries. Because the proposed model takes advantage of borrowing information across multiple countries, it outperforms an existing individual countrybased model. As fully Bayesian way has been adopted, the model provides a powerful predictive tool endowed with uncertainty quantification. Additionally, the proposed model uses countrywide covariates to adjust infection trajectories in curve fitting. A joint variable selection technique has been integrated into the proposed modeling scheme, which aimed to identify possible country-level risk factors for severe disease due to COVID-19.
Rare categories abound in a number of real-world networks and play a pivotal role in a variety of high-stakes applications, including financial fraud detection, network intrusion detection, and rare disease diagnosis. Rare category analysis (RCA) refers to the task of detecting, characterizing, and comprehending the behaviors of minority classes in a highly-imbalanced data distribution. While the vast majority of existing work on RCA has focused on improving the prediction performance, a few fundamental research questions heretofore have received little attention and are less explored: How confident or uncertain is a prediction model in rare category analysis? How can we quantify the uncertainty in the learning process and enable reliable rare category analysis?To answer these questions, we start by investigating miscalibration in existing RCA methods. Empirical results reveal that stateof-the-art RCA methods are mainly over-confident in predicting minority classes and under-confident in predicting majority classes. Motivated by the observation, we propose a novel individual calibration framework, named CaliRare, for alleviating the unique challenges of RCA, thus enabling reliable rare category analysis. In particular, to quantify the uncertainties in RCA, we develop a node-level uncertainty quantification algorithm to model the overlapping support regions with high uncertainty; to handle the rarity of minority classes in miscalibration calculation, we generalize the distribution-based calibration metric to the instance level and propose the first individual calibration measurement on graphs named Expected Individual Calibration Error (EICE). We perform extensive experimental evaluations on real-world datasets, including rare category characterization and model calibration tasks, which demonstrate the significance of our proposed framework.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.